Type 2 Neurofibromatosis

Type 2 Neurofibromatosis are rare inherited autosomal dominant diseases caused by the NF2 gene. It is characterized by the growth of noncancerous tumors in the nervous system, specifically along the auditory nerve. Symptoms include hearing loss, tinnitus, and balance problems. Here is the latest research on Type 2 Neurofibromatosis.

September 23, 2020
Open Access

Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling

JCI Insight
Zhiguo ChenLu Q Le
June 20, 2020

Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas

The Annals of Otology, Rhinology, and Laryngology
Matthew J UrbanR Mark Wiet
July 10, 2020
Open Access

High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma

Acta Neuropathologica Communications
Mark RaffeldMark R Gilbert
June 11, 2020
Case Report
Open Access

Isolated colonic neurofibroma, a rare tumor: A case report and review of literature

World Journal of Clinical Cases
Sara GhoneimDalbir Sandhu
June 27, 2020

Medical management of meningiomas

Handbook of Clinical Neurology
Ugonma N Chukwueke, Patrick Y Wen
July 4, 2020
Review

Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas

Current Oncology Reports
Christine Cordova, Sylvia C Kurz
June 17, 2020
Open Access

Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma

The Journal of Pathology. Clinical Research
Karim H SabaKarolin H Nord
August 15, 2020
Review
Open Access

Role of Kindlin-2 in cancer progression and metastasis

Annals of Translational Medicine
Wei WangKhalid Sossey-Alaoui
July 29, 2020

Management of Glioblastoma Multiforme by Phytochemicals: Applications of Nanoparticle Based Targeted Drug Delivery System

Current Drug Targets
Sayed Md MumtazFaheem Hyder Pottoo
June 9, 2020

Surgical management of peripheral nerve sheath tumours in children, with special consideration of neurofibromatoses

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Julian ZipfelMartin U Schuhmann
July 6, 2020

Ante-natal counseling in phacomatoses

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Dana Brabbing-Goldstein, Shay Ben-Shachar
August 17, 2020

The Role of Neuro-Ophthalmologists in the Care of Patients With Neurofibromatosis Type 2

Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
Klara Landau
July 8, 2020

Virtual mind-body treatment for adolescents with neurofibromatosis: Study protocol for a single-blind randomized controlled trial

Contemporary Clinical Trials
Mira ReichmanAna-Maria Vranceanu
June 18, 2020
Open Access

Managing NF2-associated vestibular schwannomas in children and young adults: review of an institutional series regarding effects of surgery and bevacizumab on growth rates, tumor volume, and hearing quality

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Isabel GugelMartin Ulrich Schuhmann
July 15, 2020

NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas

Cancer Immunology, Immunotherapy : CII
John W RutlandMary Fowkes
August 9, 2020
Review

Available Therapies for Patients with Neurofibromatosis-Related Nervous System Tumors

Current Treatment Options in Oncology
Roy E Strowd

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

© 2020 Meta ULC. All rights reserved
/feed-previews/neurofibromatosis-2/16c1c9a0-494e-4ac6-87b3-acf1bdfd0893